(Q39768978)

14 September 2017

title

Marked enhancement of antigen-specific T-cell responses by IL-7-fused nonlytic, but not lytic, Fc as a genetic adjuvant (English)

1 reference

14 September 2017

6

Young-Chul Sung

1 reference

14 September 2017

Hyo Jung Nam

1

1 reference

14 September 2017

Mi-Young Song

2

1 reference

14 September 2017

Dong-Hoon Choi

3

1 reference

14 September 2017

Se-Hwan Yang

4

1 reference

14 September 2017

Hyun-Tak Jin

5

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

European Journal of Immunology

14 September 2017

published in

1 reference

14 September 2017

volume

40

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

351-358

1 reference

Engineered antibodies with increased activity to recruit complement

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Cutting edge: mechanism of enhancement of in vivo cytokine effects by anti-cytokine monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Differential regulation of antigen-specific CD8+ T cell responses by IL-12p40 in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

Cytokines and T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Role of interleukin-7 in bone and T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Common gamma chain cytokines: dissidence in the details

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Metabolic properties of IgG subclasses in man

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Increasing the serum persistence of an IgG fragment by random mutagenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

FcgammaR: The key to optimize therapeutic antibodies?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.200939271

1 reference

7 January 2021

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Functions of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: correlation to function in a growth cone collapse assay

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Expression and function of the interleukin 7 receptor in murine lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Adenovirus-mediated gene transfer of interleukin-23 shows prophylactic but not therapeutic antitumor effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939271

7 January 2021

Identifiers

DOI

10.1002/EJI.200939271

1 reference

14 September 2017

1 reference